Aricept and Inflammatory oedema reaction - a phase IV clinical study of FDA data

Summary:

Inflammatory oedema reaction is reported only by a few people who take Aricept.

The phase IV clinical study analyzes which people take Aricept and have Inflammatory oedema reaction. It is created by eHealthMe based on reports of 22,849 people who have side effects while taking Aricept from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 27, 2022

22,849 people reported to have side effects when taking Aricept.
Among them, 2 people (0.01%) have Inflammatory oedema reaction.


What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 23,863 Aricept users for its effectiveness, alternative drugs and more.

What is Inflammatory oedema reaction?

Inflammatory oedema reaction (swelling from excessive accumulation of watery fluid in cells, tissue cause reaction) is found to be associated with 29 drugs by eHealthMe.

Number of Aricept and Inflammatory oedema reaction reports submitted per year:

Could Aricept cause Inflammatory oedema reaction?

Gender of people who have Inflammatory oedema reaction when taking Aricept *:

  • female: 50 %
  • male: 50 %

Age of people who have Inflammatory oedema reaction when taking Aricept *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Aricept *:

  1. Valproic Acid: 1 person, 50.00%

Common side effects people have besides Inflammatory oedema reaction *:

  1. Weakness: 1 person, 50.00%
  2. Serum Ferritin Increased: 1 person, 50.00%
  3. Scar: 1 person, 50.00%
  4. Rash Erythematous (redness of the skin): 1 person, 50.00%
  5. Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration): 1 person, 50.00%
  6. Joint Pain: 1 person, 50.00%
  7. Hyperkalemia (damage to or disease of the kidney): 1 person, 50.00%
  8. Fever: 1 person, 50.00%
  9. Fall: 1 person, 50.00%
  10. Eyelid Oedema (eyelids are swollen and contain excessive fluid): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aricept and have Inflammatory oedema reaction?

Check whether Inflammatory oedema reaction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Inflammatory oedema reaction and when was it recovered:

Expand to all the drugs that have ingredients of donepezil hydrochloride:

Alternative drugs to, pros and cons of Aricept:

Common Aricept side effects:

Browse all side effects of Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Inflammatory oedema reaction treatments and more:

COVID vaccines that are related to Inflammatory oedema reaction:

All the drugs that are associated with Inflammatory oedema reaction:

All the conditions that are associated with Inflammatory oedema reaction:

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride (the active ingredients of Aricept) and Aricept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: